MONTREAL - Jubilant DraxImage Inc., a wholly owned subsidiary of Jubilant Pharma Limited, is pleased to announce the receipt of the CE Mark certificate for its state-of-the-art RUBY Rubidium Elution ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc. announced today it has appointed James Kaufman as Director Marketing, PET Products effective immediately. Reporting, to Michael Rossi, President, ...
MONTREAL--(BUSINESS WIRE)--Jubilant DraxImage Inc., (“DraxImage”) www.draximage.com, a wholly Owned Subsidiary of Jubilant Pharma Ltd, announced today that the U.S. Food and Drug Administration has ...
Jubilant DraxImage Inc. is also a leading supplier of I-131 radiopharmaceuticals in North America, used for the diagnosis and treatment of thyroid disorder and cancer. Jubilant DraxImage Inc. products ...
At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions. Jubilant Life Sciences on Tuesday said its wholly-owned subsidiary has received approval ...
Jubilant DraxImage Inc. (“DraxImage”) and Cyclopharm Limited (“CYC”) are pleased to announce the signing of a term sheet, subject to satisfactory due diligence and execution of the Definitive ...
Draximage will radiolabel some Med Discovery protein drugs to analyze effectiveness. Med Discovery and Draximage are collaborating to explore the combination of the former’s targeted protein ...
DRAXIMAGE, the radiopharmaceutical division of DRAXIS Health, has filed its DRAXIMAGE Sestamibi with European regulatory authorities. DRAXIMAGE Sestamibi is a generic kit for the preparation of Tc-99m ...
Jubilant DraxImage Inc. (“DraxImage”) is pleased to announce delivery of the first commercial shipment of HICON® Sodium Iodine I-131 Solution USP to Bogota ...
Shares of Jubilant Life Sciences today ended with over 12 percent gains, adding Rs 1,224.82 crore to its market valuation, after the company said its subsidiary has signed long-term contracts in the ...
Addition of Mr. Kevin Brooks strengthens further Jubilant DraxImage expertise MONTREAL, April 2, 2013 /PRNewswire/ - Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback